DK172036B1 - Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf - Google Patents

Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf Download PDF

Info

Publication number
DK172036B1
DK172036B1 DK174984A DK174984A DK172036B1 DK 172036 B1 DK172036 B1 DK 172036B1 DK 174984 A DK174984 A DK 174984A DK 174984 A DK174984 A DK 174984A DK 172036 B1 DK172036 B1 DK 172036B1
Authority
DK
Denmark
Prior art keywords
factor viii
coagulant
polypeptides
viii
human factor
Prior art date
Application number
DK174984A
Other languages
Danish (da)
English (en)
Other versions
DK174984D0 (da
DK174984A (da
Inventor
Theodore S Zimmerman
Carol A Fulcher
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27046849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK172036(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK174984D0 publication Critical patent/DK174984D0/da
Publication of DK174984A publication Critical patent/DK174984A/da
Application granted granted Critical
Publication of DK172036B1 publication Critical patent/DK172036B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK174984A 1983-03-31 1984-03-30 Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf DK172036B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48110583A 1983-03-31 1983-03-31
US48110583 1983-03-31
US55650883A 1983-11-30 1983-11-30
US55650883 1983-11-30

Publications (3)

Publication Number Publication Date
DK174984D0 DK174984D0 (da) 1984-03-30
DK174984A DK174984A (da) 1984-10-01
DK172036B1 true DK172036B1 (da) 1997-09-22

Family

ID=27046849

Family Applications (2)

Application Number Title Priority Date Filing Date
DK174984A DK172036B1 (da) 1983-03-31 1984-03-30 Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf
DK050497A DK50497A (da) 1983-03-31 1997-05-02 Monoklonale antistoffer over for nye faktor VIII-koaguleringspolypeptider

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK050497A DK50497A (da) 1983-03-31 1997-05-02 Monoklonale antistoffer over for nye faktor VIII-koaguleringspolypeptider

Country Status (12)

Country Link
EP (3) EP0770396A3 (de)
JP (2) JPH0829089B2 (de)
AT (2) ATE135400T1 (de)
AU (1) AU572128B2 (de)
CA (1) CA1341506C (de)
DE (2) DE3486453T2 (de)
DK (2) DK172036B1 (de)
FI (1) FI841281A (de)
IE (2) IE80638B1 (de)
NO (1) NO167533C (de)
SG (2) SG49675A1 (de)
ZA (1) ZA842418B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
US4716117A (en) * 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
DE122004000028I1 (de) * 1984-01-12 2004-09-30 Chiron Corp F}r Faktor-VIIIc kodierende DNA-Sequenzen und verwandte DNA-Konstruktionen.
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
ATE66249T1 (de) * 1984-01-12 1991-08-15 Chiron Corp Hybridom-zellinien und monoklonale antikoerper gegen faktor-viii-c.
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
US5004804A (en) * 1984-01-12 1991-04-02 Nordisk Gentofte Method and composition for preparation of factor VIIIC
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
WO1988000210A1 (en) * 1986-06-24 1988-01-14 Nordisk Gentofte A/S A process for producing a coagulation active complex of factor viii fragments
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
EP0690126B1 (de) 1987-06-12 2001-11-28 Baxter Aktiengesellschaft Proteine mit Faktor VIII Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende Zusammensetzungen
IL88309A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides for use in the purification of factor viii
FR2662166A1 (fr) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption.
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
DK2130554T3 (da) 1999-02-22 2012-12-03 Univ Connecticut Albuminfrie faktor VIII-præparater
WO2003013244A1 (en) 2001-08-03 2003-02-20 The Government Of The United State Of America, As Represented By The Secretary Of The Department Of Health And Human Services Oral treatment of hemophilia
AU2009313325B2 (en) 2008-11-07 2014-05-01 Takeda Pharmaceutical Company Limited Factor VIII formulations
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364936A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human monocyte antigen and methods of preparing same
US4364937A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human T cell antigen and methods of preparing same
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C

Also Published As

Publication number Publication date
ATE135400T1 (de) 1996-03-15
EP0123945A1 (de) 1984-11-07
DE3486453D1 (de) 1997-08-21
IE960783L (en) 1984-09-30
SG49675A1 (en) 1998-06-15
NO167533C (no) 1991-11-13
AU572128B2 (en) 1988-05-05
DK50497A (da) 1997-05-02
IE80858B1 (en) 1999-04-21
AU2627284A (en) 1984-10-04
DK174984D0 (da) 1984-03-30
EP0770396A2 (de) 1997-05-02
FI841281A0 (fi) 1984-03-30
JPS59184130A (ja) 1984-10-19
DE3486423T2 (de) 1996-09-19
ATE155490T1 (de) 1997-08-15
EP0770396A3 (de) 1997-07-23
JPH0829089B2 (ja) 1996-03-27
DE3486423D1 (de) 1996-04-18
NO841277L (no) 1984-10-01
IE80638B1 (en) 1998-10-21
FI841281A (fi) 1984-10-01
IE840788L (en) 1984-09-30
EP0123945B2 (de) 2000-04-19
SG48229A1 (en) 1998-04-17
DE3486453T2 (de) 1998-02-26
DK174984A (da) 1984-10-01
EP0123945B1 (de) 1996-03-13
NO167533B (no) 1991-08-05
CA1341506C (en) 2006-06-06
EP0561427A1 (de) 1993-09-22
EP0561427B1 (de) 1997-07-16
JPH0638790A (ja) 1994-02-15
ZA842418B (en) 1984-11-28
DE3486423T3 (de) 2001-02-08

Similar Documents

Publication Publication Date Title
DK172036B1 (da) Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf
US4877614A (en) Biologically active fragments of human antihemophilic factor and method for preparation thereof
Clezardin et al. Complex formation of human thrombospondin with osteonectin
EP0182372A2 (de) Faktor-VIII-gerinnende Polypeptide
Pengo et al. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β2-glycoprotein I is bound to a suitable surface
US4649132A (en) Treatment of Factor VIII inhibitors
US4886876A (en) Factor VIII coagulant polypeptides
Warn-Cramei et al. Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor)
JP2006316062A (ja) 因子ｖｉｉｉの抗原ポリペプチド配列、その断片および／またはエピトープ
US4857635A (en) Factor VIII coagulant polypeptides and monoclonal antibodies tof them
Robitzki et al. cDNA structure and expression of calpactin, a peptide involved in Ca2+-dependent cell aggregation in sponges
JPH02296A (ja) ８因子のフォン・ビルブラント因子結合ドメイン
EP0190099A2 (de) Polypeptidfaktoren aus Kolostrum
US5214033A (en) Factor VIII coagulant polypeptides
Vingsbo et al. Association of pepsin with type II collagen (CII) breaks control of CII autoimmunity and triggers development of arthritis in rats
US5101016A (en) Factor VIII coagulant polypeptides and monoclonal antibodies to them
Kosaka et al. Hyperviscosity syndrome associated with an idiopathic monoclonal IgA-rheumatoid factor
JPH058679B2 (de)
Stiehm et al. Some immunologic properties of papain digest fragments of multiple myeloma proteins
US5747337A (en) Factor VIII coagulant polypeptides and monoclonal antibodies to them
Leung et al. Isolation and characterization of monoclonal antibody directed against bovine αs2-casein
Boström et al. Evidence for a structural relationship between apoB75 kDa and human plasma apolipoprotein B100, from translation of human liver mRNA in vitro and immunochemical studies with monoclonal and polyclonal antibodies
JPH0753757B2 (ja) モノクローナル抗体及びその使用方法
JPH0794475B2 (ja) 純粋なエリスロポエチンの製造法
US5272255A (en) Polypeptide factors from colostrum

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired